[1] SEEGER C,MASON W S.Hepatitis B virus biology[J].Microbiol Mol Biol Rev,2000,64(1):51-68.
[2] JIEANU C F,UNGUREANU B S,SANDULESCU D L,et al. Quantification of liver fibrosis in chronic hepatitis B virus infection[J].J Med Life,2015,8(3):285-290.
[3] HUANG R,JIANG N,YANG R,et al. Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B[J].Exp Ther Med,2016,11(5):1673-1677.
[4] WAI C T,GREENSON J K,FONTANA R J,et al.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology,2003,38(2):518-526.
[5] STERLING R K,LISSEN E,CLUMECK N,et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection[J].Hepatology,2006,43(6):1317-1325.
[6] 中华医学会肝病学分会.慢性乙型肝炎防治指南(2015更新版)[J].胃肠病学,2016,23(4):915-932.
[7] 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华内科杂志,2000,40(6):324-329.
[8] 李爽,许多,李书,等.谷胱甘肽含片联合拉米夫定和阿德福韦酯治疗慢性乙型肝炎近期与远期临床疗效评价[J].现代医学,2017,45(9):1243-1246.
[9] 钤培国,廉晓晓,郭晓霞.无创诊断模型诊断乙型肝炎和肝硬化患者肝纤维化价值评价[J].实用肝脏病杂志,2016,19(5):578-582. |